Isolated tricuspid valve surgery: impact of aetiology and clinical presentation on outcomes

Author:

Dreyfus Julien1ORCID,Flagiello Michele2,Bazire Baptiste3ORCID,Eggenspieler Florian4,Viau Florence5ORCID,Riant Elisabeth6,Mbaki Yannick7,Bohbot Yohann89,Eyharts Damien10ORCID,Senage Thomas11,Dubrulle Henri12ORCID,Nicol Martin1ORCID,Doguet Fabien1314,Nguyen Virginia1,Coisne Augustin1215,Le Tourneau Thierry16,Lavie-Badie Yoan10ORCID,Tribouilloy Christophe89ORCID,Donal Erwan7ORCID,Tomasi Jacques17ORCID,Habib Gilbert518ORCID,Selton-Suty Christine4ORCID,Raffoul Richard19,Iung Bernard20ORCID,Obadia Jean-François2ORCID,Messika-Zeitoun David21ORCID

Affiliation:

1. Cardiology Department, Centre Cardiologique du Nord, 32-36 rue des moulins gémeaux, Saint-Denis 93200, France

2. Department of Cardiovascular Surgery and Transplantation, Louis Pradel Cardiovascular Hospital, Claude Bernard University, 59 Boulevard Pinel, 69500 Bron, France

3. Department of Cardiology, Bichat Claude Bernard Hospital, 46 Rue Henri Huchard, 75018 Paris, France

4. Department of Cardiology, University Hospital of Nancy-Brabois, 29 Avenue du Maréchal de Lattre de Tassigny, 54035 Nancy, France

5. Cardiology Department, APHM, La Timone Hospital, 278 Rue Saint-Pierre, 13005 Marseille, France

6. Cardiology Department, Expert Valve Center, Henri Mondor Hospital, 51 Avenue du Maréchal de Lattre de Tassigny, 94010 Créteil, France

7. Cardiology Department, CHU de RENNES, LTSI UMR1099, INSERM, Université de Rennes-1, 2 Rue Henri le Guilloux, 35000 Rennes, France

8. Department of Cardiology, Amiens University Hospital, 1 Rue du Professeur Christian Cabrol, 80054 Amiens, France

9. UR UPJV 7517, Jules Verne University of Picardie, 51 Boulevard de Châteaudun, 80000 Amiens, France

10. Department of Cardiology, Rangueil University Hospital, 9 Place Lange, 31300 Toulouse, France

11. Department of Cardiac Surgery, INSERM 1246, Université de Nantes, CHU de Nantes, 8 Quai Moncousu, 44007 Nantes, France

12. Department of Clinical Physiology and Echocardiography – Heart Valve Clinic, CHU Lille, 2 Avenue Oscar Lambret, 59000 Lille, France

13. Service de chirurgie cardiovasculaire et thoracique, CHU Charles Nicolle, 37 Boulevard Gambetta, 76000 Rouen, France

14. Normandie Univ, Unirouen, INSERM U1096, Rouen 76000, France

15. Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, Lille F-59000, France

16. Université de Nantes, CHU de Nantes, CNRS, INSERM, l’institut du thorax, Nantes F-44000, France

17. Department of Cardiac Surgery, CHU de RENNES, Université de Rennes-1, 2 Rue Henri le Guilloux, 35000 Rennes, France

18. Aix Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005 Marseille, France

19. Department of Cardiac Surgery, AP-HP, Bichat Hospital, 46 Rue Henri Huchard, 75018 Paris, France

20. Cardiology Department, AP-HP, DHU Fire, Bichat Hospital, Université de Paris, 46 Rue Henri Huchard, 75018 Paris, France

21. Department of Cardiology, University of Ottawa Heart Institute, 40 ruskin street, Ottawa, Ontario, Canada

Abstract

Abstract Aims The aim of this study was to identify determinants of in-hospital and mid-term outcomes after isolated tricuspid valve surgery (ITVS) and more specifically the impact of tricuspid regurgitation (TR) mechanism and clinical presentation. Methods and results Among 5661 consecutive adult patients who underwent a tricuspid valve (TV) surgery at 12 French tertiary centres in 2007–2017 collected from a mandatory administrative database, we identified 466 patients (8% of all tricuspid surgeries) who underwent an ITVS. Most patients presented with advanced disease [47% in New York Heart Association (NYHA) III/IV, 57% with right-sided heart failure (HF) signs]. Tricuspid regurgitation was functional in 49% (22% with prior left-sided heart valve surgery and 27% isolated) and organic in 51% (infective endocarditis in 31% and other causes in 20%). In-hospital mortality and major complications rates were 10% and 31%, respectively. Rates of survival and survival free of HF readmission were 75% and 62% at 5 years. Patients with functional TR incurred a worse in-hospital mortality than those with organic TR (14% vs. 6%, P = 0.004), but presentation was more severe. Independent determinants of outcomes were NYHA Class III/IV [odd ratios (OR) = 2.7 (1.2–6.1), P = 0.01], moderate/severe right ventricular dysfunction [OR = 2.6 (1.2–5.8), P = 0.02], lower prothrombin time [OR = 0.98 (0.96–0.99), P = 0.008], and with borderline statistical significance, right-sided HF signs [OR = 2.4 (0.9–6.5), P = 0.06] while TR mechanism was not [OR = 0.7 (0.3–1.8), P = 0.88]. Conclusion Isolated TV surgery was associated with high mortality and morbidity, both in hospital and during follow-up, predicted by the severity of the presentation but not by TR mechanism. Our results suggest that TV intervention should be performed earlier in the course of the disease.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3